603 related articles for article (PubMed ID: 29321330)
1. Glycosyl-Phosphatidylinositol-Anchored Anti-HIV Env Single-Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity.
Misra A; Gleeson E; Wang W; Ye C; Zhou P; Kimata JT
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321330
[TBL] [Abstract][Full Text] [Related]
2. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice.
Ye C; Wang W; Cheng L; Li G; Wen M; Wang Q; Zhang Q; Li D; Zhou P; Su L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881659
[TBL] [Abstract][Full Text] [Related]
3. Engineered CD4 T cells expressing a membrane anchored viral inhibitor restrict HIV-1 through
Wang W; Truong K; Ye C; Sharma S; He H; Liu L; Wen M; Misra A; Zhou P; Kimata JT
Front Immunol; 2023; 14():1167965. PubMed ID: 37781368
[TBL] [Abstract][Full Text] [Related]
4. GPI-anchored single chain Fv--an effective way to capture transiently-exposed neutralization epitopes on HIV-1 envelope spike.
Wen M; Arora R; Wang H; Liu L; Kimata JT; Zhou P
Retrovirology; 2010 Oct; 7():79. PubMed ID: 20923574
[TBL] [Abstract][Full Text] [Related]
5. Cell membrane-anchored anti-HIV single-chain antibodies and bifunctional inhibitors targeting the gp41 fusion protein: new strategies for HIV gene therapy.
Chen Y; Jin H; Tang X; Li L; Geng X; Zhu Y; Chong H; He Y
Emerg Microbes Infect; 2022 Dec; 11(1):30-49. PubMed ID: 34821542
[TBL] [Abstract][Full Text] [Related]
6. A Membrane-Anchored Short-Peptide Fusion Inhibitor Fully Protects Target Cells from Infections of Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.
Tang X; Jin H; Chen Y; Li L; Zhu Y; Chong H; He Y
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462566
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human immunodeficiency virus (HIV-1) infectivity by expression of poorly or broadly neutralizing antibodies against Env in virus-producing cells.
Wang Q; Zhang S; Nguyen HT; Sodroski J
J Virol; 2024 Feb; 98(2):e0159423. PubMed ID: 38289101
[TBL] [Abstract][Full Text] [Related]
9. Reverted HIV-1 Mutants in CD4
Lu W; Li TW; Phillips S; Wu L
Microbiol Spectr; 2021 Dec; 9(3):e0165321. PubMed ID: 34935422
[TBL] [Abstract][Full Text] [Related]
10. The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1.
Liu L; Wang W; Matz J; Ye C; Bracq L; Delon J; Kimata JT; Chen Z; Benichou S; Zhou P
J Virol; 2016 Dec; 90(23):10642-10659. PubMed ID: 27654286
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes.
Lee YM; Tang XB; Cimakasky LM; Hildreth JE; Yu XF
J Virol; 1997 Feb; 71(2):1443-52. PubMed ID: 8995670
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages.
Musich T; O'Connell O; Gonzalez-Perez MP; Derdeyn CA; Peters PJ; Clapham PR
Retrovirology; 2015 Mar; 12():25. PubMed ID: 25809903
[TBL] [Abstract][Full Text] [Related]
13. Envelope Glycoprotein Internalization Protects Human and Simian Immunodeficiency Virus-Infected Cells from Antibody-Dependent Cell-Mediated Cytotoxicity.
von Bredow B; Arias JF; Heyer LN; Gardner MR; Farzan M; Rakasz EG; Evans DT
J Virol; 2015 Oct; 89(20):10648-55. PubMed ID: 26269175
[TBL] [Abstract][Full Text] [Related]
14. The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell Transmission.
Santos da Silva E; Mulinge M; Lemaire M; Masquelier C; Beraud C; Rybicki A; Servais JY; Iserentant G; Schmit JC; Seguin-Devaux C; Perez Bercoff D
PLoS One; 2016; 11(9):e0161596. PubMed ID: 27598717
[TBL] [Abstract][Full Text] [Related]
15. Vpr Enhances HIV-1 Env Processing and Virion Infectivity in Macrophages by Modulating TET2-Dependent IFITM3 Expression.
Wang Q; Su L
mBio; 2019 Aug; 10(4):. PubMed ID: 31431548
[TBL] [Abstract][Full Text] [Related]
16. Dual Pathways of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trafficking Modulate the Selective Exclusion of Uncleaved Oligomers from Virions.
Zhang S; Nguyen HT; Ding H; Wang J; Zou S; Liu L; Guha D; Gabuzda D; Ho DD; Kappes JC; Sodroski J
J Virol; 2021 Jan; 95(3):. PubMed ID: 33148792
[TBL] [Abstract][Full Text] [Related]
17. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells.
Vyakarnam A; Eyeson J; Teo I; Zuckerman M; Babaahmady K; Schuitemaker H; Shaunak S; Rostron T; Rowland-Jones S; Simmons G; Clapham P
AIDS; 2001 Sep; 15(13):1613-26. PubMed ID: 11546935
[TBL] [Abstract][Full Text] [Related]
20. Mutations in HIV-1 envelope that enhance entry with the macaque CD4 receptor alter antibody recognition by disrupting quaternary interactions within the trimer.
Boyd DF; Peterson D; Haggarty BS; Jordan AP; Hogan MJ; Goo L; Hoxie JA; Overbaugh J
J Virol; 2015 Jan; 89(2):894-907. PubMed ID: 25378497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
